Podcasts about Cancer vaccine

(0:00) Bestie intros: Recapping recent interviews and the state of American science (3:31) China's Robot Olympics, Optimus update, Grok Bot (9:05) Nvidia and Salesforce rip after big earnings: AI Capex Bubble and SaaSpocalypse narratives get reversed (33:32) Bessent gets called out by Druckenmiller for bond market interference (1:01:33) AI writing controversy: Druck used AI to write his WSJ Op-ed (1:15:00) CIA Chief visits Moscow, Meta's settlement and new teen rules (1:22:52) Science Corner: Moderna's mRNA cancer vaccine Come hang with the Besties at the All-In Summit | September 13-15: http://theallinsummit.com Follow the besties: https://x.com/chamath https://x.com/Jason https://x.com/DavidSacks https://x.com/friedberg Follow on X: https://x.com/theallinpod Follow on Instagram: https://www.instagram.com/theallinpod Follow on TikTok: https://www.tiktok.com/@allin Follow on LinkedIn: https://www.linkedin.com/company/allinpod Intro Music Credit: https://rb.gy/tppkzl https://x.com/yung_spielburg Intro Video Credit: https://x.com/TheZachEffect Referenced in the show: https://www.cnbc.com/2026/08/27/nvidia-nvda-q2-earnings.html https://finance.yahoo.com/markets/stocks/article/how-nvidia-silenced-the-bears-105017893.html https://nvidianews.nvidia.com/news/nvidia-announces-financial-results-for-second-quarter-fiscal-2027 https://polymarket.com/event/largest-company-end-of-december-2026 https://www.cnbc.com/2026/08/18/treasury-yields-.html https://www.cnbc.com/2026/08/24/bessent-1-trillion-treasury-general-account-bond-buybacks.html https://seekingalpha.com/news/4636322-wall-street-sees-bessent-putting-fear-of-god-into-bond-vigilantes https://www.wsj.com/opinion/let-the-bond-market-speak-81529d74 https://www.wsj.com/world/cia-director-john-ratcliffe-makes-surprise-trip-to-moscow-c1c68fa6 https://polymarket.com/event/russia-x-ukraine-ceasefire-agreement-by

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ's Xavier Martinez traces Moderna's wild ride from scrappy startup to the frontier of can treatment. Ryan Knutson hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - The Creator of the Record-Setting Covid Vaccine Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Personalised vaccines could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. Canada's oil market is flourishing, despite the trade war. And, why we will always love Dolly Parton.Guests and host:Natasha Loder, health editorSarah Lawrynuik, deputy editor of “The Intelligence”Jon Fasman, senior culture correspondentJason Palmer, co-host of “The Intelligence”Topics covered: Cancer, immunotherapy, vaccines, mRNAOil, Canada, trade war, tariffsDolly Parton, country musicListen to what matters most, from global politics and business to science and technology—subscribe to The Economist. Hosted on Acast. See acast.com/privacy for more information.

Personalised vaccines could offer a breakthrough in the fight against cancer. Our correspondent analyses the latest trial. Canada's oil market is flourishing, despite the trade war. And, why we will always love Dolly Parton.Guests and host:Natasha Loder, health editorSarah Lawrynuik, deputy editor of “The Intelligence”Jon Fasman, senior culture correspondentJason Palmer, co-host of “The Intelligence”Topics covered: Cancer, immunotherapy, vaccines, mRNAOil, Canada, trade war, tariffsDolly Parton, country musicListen to what matters most, from global politics and business to science and technology—subscribe to The Economist. Hosted on Acast. See acast.com/privacy for more information.

P.M. Edition for Aug. 26. Tech reporter Meghan Bobrowsky tells us why the Meta settlement could change how teenagers use some of the world's most popular apps. Plus, the FDA approves a milestone therapy for pancreatic cancer. WSJ reporter Xavier Martinez discusses how the nearly $40,000-a-month drug from Revolution Medicines could change patient outcomes of one the deadliest cancers. And the FBI shuts down a sprawling hacking network linked to China that targeted NASA, the Federal Reserve and critical infrastructure. Sabrina Siddiqui hosts. Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of The Brainstorm, Sam, Nick, and Brett break down Merck and Moderna's positive Phase 3 results for a personalized mRNA cancer vaccine, a treatment custom-built from each patient's own tumor that cut mortality from advanced melanoma by roughly 50% versus the standard of care. The team digs into cost, manufacturing scale, and why the capital poured into mRNA during COVID may be paying off in oncology. Then Brett reports back from a weekend with Grok Bot, which recovered $75 of his wife's forgotten escrow money on its first task, and the team debates why multiplayer agents could be the real threat to Microsoft's enterprise moat.Key Points From This Episode:How a custom mRNA vaccine trains the immune system against a patient's own tumor, and what Phase 3 melanoma results could mean for other cancersWhy $200K–$300K per treatment limits early use, and what we believe has to change for personalized oncology to scaleWhy agents that live inside team chat, not one-on-one, may be the real disruption to Microsoft and SlackIf you know ARK, you know we focus on long-term innovation. But that doesn't mean we ignore breaking news. Every day, we debate the latest developments in tech and markets. Now, we're bringing those conversations to you in “The Brainstorm,” a co-production from ARK, WOLF, and Public. Tune in weekly for our quick takes on what's shaping innovation right now.Learn more about WOLF: https://wolf.financialLearn more about Public: https://public.com/Disclosure: http://arkinv.st/39rzF94

Mike talks with Dr. Mike Roizen about the cancer vaccine and more of the latest health and wellness news.

A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, representing a potentially watershed moment in cancer treatment. Scientists used mRNA technology, which was used for some Covid-19 vaccines.But that technology - and vaccines more generally - have become increasingly controversial in the United States since the Covid-19 pandemic. The Health Secretary Robert F Kennedy Jr, is a vaccine sceptic. In August 2025 cancelled $500m (£376m) in funding for mRNA vaccine research. The move impacted 22 projects being led by major pharmaceutical companies, including Pfizer and Moderna, for vaccines against bird flu and other viruses, according to Kennedy's department. We speak to Tom Whipple, host of the BBC's Inside Science programme, about the science of this new vaccine. And we ask how funding cuts for vaccine research could impact health outcomes not just for Americans, but for the world.Producers: Lucy Pawle and Sam ChantarasakDigital producer: Sam GruetMix: Travis EvansEditor: James ShieldSenior news editor: China CollinsPhoto: US Secretary of Health and Human Services Robert F. Kennedy Jr. testifies during the Senate Finance Committee's hearing on The President's Health Care Agenda on Capitol Hill in Washington, DC, USA, 04 September 2025. Credit: Shawn Thew/EPA/Shutterstock

P.M. Edition for Aug. 24. Treasury Secretary Scott Bessent says the U.S. will go after countries and companies that do business with Iran. White House economic policy reporter Brian Schwartz says it's unclear what will happen with Iran's top trading partner: China. Plus, President Trump escalates the trade conflict with Canada, threatening 50% tariffs on autos. And Heard on the Street columnist David Wainer discusses the challenges Moderna faces in fulfilling investor hopes for a sweeping new era for cancer treatment. Pierre Bienaimé hosts. The AI Therapist: A WSJ Podcast Series  Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Pour Over is a Christ-first, politically neutral news podcast. Every Monday, Wednesday, and Friday, we cover the day's biggest stories in ~10 minutes, and pair the biggest headlines with brief biblical reminders. Looking to support us? You can choose to pay ⁠here⁠. On today's episode: National Debt Tops $40T Cancer Vaccine Shows Promising Results U.S. Threatens Economic Pressure on Iran Florida Finishes Primaries Lindsay Clancy Case Nearing Conclusion U.S. & South Korea Cut Military Drills Short NIH Adviser Pleads Guilty to Concealing COVID Records Prince Harry and Family Plan Return to London Thanks to our sponsors: The Voice of the Martyrs: Give a Village Outreach Kit | vom.org/TPO Wild Alaskan: $35 off your first box | code: TPO Quince: Free shipping | quince.com/tpo AdelFi: Apply for the Harvest Bundle | https://adelfibanking.com/pourover Upside: extra 25 cents back for every gallon on your first tank of gas | code: TPO LMNT: free 8-pack with purchase | https://links.thepourover.org/LMNT_Podcast Mosh: 25% off first variety pack + 20% off subscription | code: TPO25 Serving Orphans Worldwide: Give a gift to feed a child for a month | https://servingorphans.org/thepourover MORE FROM TPO: ⁠Free newsletter⁠ ⁠Watch TPO on YouTube⁠ ⁠Download the TPO App⁠ Unless otherwise noted, all scripture references are from the Christian Standard Bible (CSB) translation. Learn more about your ad choices. Visit megaphone.fm/adchoices

Moderna stock surged over 160% after their personalized mRNA cancer vaccine intismeran, combined with Merck's Keytruda, reported a successful trial for melanoma. But after the COVID-19 vaccine debacle, can mRNA technology be trusted? Salty Cracker joins Dr. Drew LIVE to discuss the new mRNA cancer treatment, ex Dr. Fauci adviser David Morens pleading guilty to conspiracy, the now-over-$900k GoFundMe for accused murderer Lindsay Clancy (allegedly benefiting her parents), and Roysha / Royce White's WNBA draft bid. Salty Cracker is an uncensored clown world commentator known for breaking the Left with satire, shame, and ridicule. He is active on Rumble as TheSaltyCracker. Follow at https://x.com/saltycracker9 「 SUPPORT OUR SPONSORS 」 • BIOPRO - BioPro+® is a natural formula of growth factors and peptides that support how you look, feel & perform. Learn more at ⁠⁠⁠https://drdrew.com/biopro⁠⁠⁠ • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • CHAPTER - For free and unbiased Medicare help, dial (218) 521-2472 to speak with my trusted partner, Chapter, or go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://askchapter.org/drdrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options. 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Jordan and Nate pre record this one but still pack in plenty, starting with RFK's ongoing Real Food Show and a genuinely fascinating podcast episode with a very deaf Lou Ferrigno on ditching diet culture for good. From there they dig into Trump's pick for FDA commissioner, Dr. Heidi Overton, and why her ties to the recent childhood vaccine executive order have some old guard MAHA voices nervous. The big one this week is Fauci's longtime NIAID advisor pleading guilty to a federal conspiracy involving hidden COVID records, with ties back to Eco Health Alliance and the gain of function money trail. They also break down a new FDA rule closing a decades old food safety loophole, debate a splashy Moderna and Merck mRNA cancer vaccine, and wrap with a genuinely thoughtful conversation about the federal roadless rule and what it means for wildfire management out west. Equal parts hard news and honest back and forth between friends.

Hey this is Alex, welcome to... the chillest week in AI, since ... a long time. Chill, if you consider Moderna and MERK announcing a cancer vaccine and surging 115% in a day, a chill week. This week, the only two model drops we really saw came from the excellent Z.ai folks, they announced GLM 5.3, API only for now, and an amazing tiny release of Qwen 3.89 27B. In other big AI news, OpenAI announced they are pausing RL efforts (Reinforcement Learning) to focus on security and alignment post the scary AI Swarms hacking incident, dedicating up to 20% of compute towards reviewing agent thinking processes, and Stripe buying OpenRouter for a reported $8B! Sometimes the chill weeks are actually good, we're able to chat about how we use AI, what changed for us, and give our guests a bit of breathing room. This week, I invited Francesco from CUA to talk about computer use in open source + their new history plugin, Bin from HeyGen to talk about HyperFrames, a way for your agents to create videos and a breaking news guest, Jeff Huber from Chroma jumped on to talk about their new Foundations release, a unified memory for your agents! This was a great episode, I hope you'll like it, it's up here on Substack and everywhere you get your pod (Spotify, Youtube, Apple Podcasts). ThursdAI - Highest signal weekly AI news show is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.Are we being fed slop again? (Is Claude dumb again?)Before we get to releases, this week on the show, I complained, again, that I feel my AI's are degrading. If this feels like de-ja-vu to you, it's because the same happened a year ago in September 2025 (and Anthropic admitting this 2 weeks later), and ... now this happens with Fable?You see, I use pretty much the same prompts, every week, preparing for the show. This is partly my way to evaluate new models and compare to existing and previous ones while also bringing you the best researched weekly show in AI. Well, this week, one after another, Claude Fable, which is... like the best intelligence, gave me such poor output, that I couldn't believe what I'm seeing. First, literally ignoring instructions that say “hey, show me all the items I've collected and let me pick the most important ones”, Fable instead sent all of them to my research pipeline, without showing me. This has worked, consistently, without fail, for the past... year? maybe more! This worked with open source models, worked with GPT, and now Fable, a Mythos Level LLM, is doing the most basic dumb s**t possible, ignoring the main reason I even have this workflow. And this wasn't just a fluke either, when asked to create a run of show document, and given an example, Fable produced this... whatever this is. This is the same document and same format that Fable produced for me during AI Engineer which got me thinking “ok, this is AGI”, and here, given an example, I got a completely unusable artifact, despite direct instructions, structure and example! I got to say, given that privately this week, Anthropic disclosed that they have passed $65B in revenue, which is absolutely insane, this doesn't add up. So I figured, ok Alex, maybe this is your prompts or skills. But no, LDJ came in with some charts that show degradation, one from MarginLab.ai that shows significant lowering on number of tool calls and average runtime recently (this is for Opus 5) and And another chart from modelverify.ai model drift monitor showing drift scores.Do we have anoher Claude Gate on our hands? Is your Fable/Opus behaving weird lately? Or did you completely switched away to other models? OpenAI pausing RL and focusing on safetyLook, when we covered the HF hacking incident and then the pacing the frontier letter, I didn't imagine that results will come this fast, but this week, OpenAI publicly announced that they are pausing RL training, which is the last step of models, until they get their sandboxes in order and align the models better. We all agreed on stage that this is likely a very good move, and Peter was really awe-struck at the 20% dedication of resources towards reviewing thought processes of models. Is this a good enough response to the scary hacking incident? we'll see, but I think this is the right move from OpenAI, and still, waiting for the full postmortem on the OpenAI security incident. Open Source LLMsQwen3.8-27B ties GPT-5.6 Luna and runs on a 4090 (X, HF, Announcement)Following the release of their flagship, Alibaba dropped a model that became a community darling overnight, Qwen 3.8 with just 27B parameters. This “tiny” model scores 52 on the Artificial Analysis Intelligence Index, same score as GPT 5.6 Luna at Max reasoning and 51 on Agentic index, beating Opus 4.8 MaxAll while running at around 68t/s on a 4090 GPU, and around 40 on max via MLX, hell it even does 11t/s on Xenova's WebGPU kernels right in the browser! This model exploded on the HuggingFace hub, with tons of quants, over 152 fine-tunes, it was downloaded over 10M times overall

BUY CAST BREW COFFEE TO SUPPORT THE SHOW - https://castbrew.com/ Become A Member And Protect Our Work at http://www.timcast.com Host: Tim Pool @Timcast (everywhere) | https://www.shoutout.fans/timpool My Second Channel - https://www.youtube.com/timcastnews Podcast Channel - https://www.youtube.com/TimcastIRL For advertising inquiries please email sponsorships@rumble.com

Drugmakers Merck and Moderna unveil a study claiming an experimental mRNA vaccine reduced recurrence of melanoma. Progressive Democrats surprise analysts with primary wins in Florida. And a former Ukrainian defense minister says Volodymyr Zelenskyy should face a wartime election. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Headlines: – Welcome to Mo News + Tom Holland Workout (02:00) – A New mRNA Vaccine Could Prevent Melanoma From Returning (05:30) – Trump Says He'll Meet North Korea's Kim Jong Un Later This Year (08:50) – U.S. Conducting Stealth Operation To Transport  Oil Through Hormuz (12:30) – Meta Trial: Whistleblower says Zuckerberg Lied About Concern For Child Safety (19:00) – Penn State Fraternity Members Are Charged in Cocaine Trafficking Case (21:30) – Why Factory-Built Homes are Reaching the Suburbs (25:20) – Harry and Meghan Will Move Back to Britain (27:45) – LinkedIn Has Accidentally Become a Dating Site—Despite Its No-Romance Rules (31:30) – On This Day In History (36:30) Thanks To Our Sponsors:  – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – LMNT | Free Sample Pack with any LMNT drink mix or 12oz cans purchase – ⁠Boll & Branch⁠ – 20% off first order, plus free shipping | Code: MONEWS

The news to know for Thursday, August 20, 2026! We'll tell you how the U.S. national debt hit a record $40 trillion and what it could mean for everyday Americans. Also, what we know about President Trump's pick to lead the FDA. And about a new melanoma vaccine that could be on the market as soon as next year. Plus, where some temperatures have broken all-time records, why some U.S. soldiers are being offered time off to play a video game, and how the NFL plans to expand overseas. Those stories and even more news to know in about 15 minutes!    Join us every Mon-Fri for more daily news roundups!  See sources: https://www.theNewsWorthy.com/shownotes Become an INSIDER to get AD-FREE episodes here: https://www.theNewsWorthy.com/insider Get The NewsWorthy MERCH here: https://thenewsworthy.dashery.com/ Sponsors: Sleep cooler this summer with Boll & Branch. Get 15% off your first order plus free shipping at BollAndBranch.com/newsworthy with code newsworthy For a limited time, get 60% off your first order, plus free shipping and free treats for life, when you head to Smalls.com/NEWSWORTHY. To advertise on our podcast, please reach out to ad-sales@libsyn.com 

This week Merck (known as MSD in Europe) and Moderna announced that a personalised cancer vaccine had significantly improved the outcomes of melanoma patients. Is the era of the cancer vaccine, at last, upon us? What does that mean? Anne Willis, a cancer cell biologist at the Medical Research Council, joins us to discuss. In just a few weeks the Royal Society will be putting out the red carpet as the most coveted prize in non-fiction science is about to be awarded. We will be speaking weekly to the shortlisted authors for the Royal Society Trivedi Book Prize, and we are starting with Kit Chapman, author of the Age of Alchemy. Plus, Penny Sarchet has, like an alchemist of old, been scouring the most obscure texts and journals to bring us the latest science knowledge. Presenter: Tom Whipple Producers: Alex Mansfield, Tabitha Taylor Buck, Katie Tomsett, Keiran Manetta-Jones Editor: Ilan Goodman Production Co-ordinator: Jana Bennett-Holesworth

A new skin cancer vaccine helps kill melanoma.See omnystudio.com/listener for privacy information.

Moderna shares soared more than 172% after strong results for its vaccine for melanoma skin cancer. Elsewhere, the Evergrande saga came to a dramatic conclusion in a Shenzhen court. And what will Walmart spend its $3 billion Trump tariffs rebate on?World Business Express - Finance, economy and business news from BBC journalists around the world. The stories that matter: World Business Express brings you the essentials on the fast-changing global economy. What forces are driving the markets and industry? Hear unique insight from top CEOs, investors, economic thinkers and small business bosses.

U.S. government debt tops $40 trillion for the first time, adding to fears of a brewing fiscal crisis. The IDF investigates its own troops over five incidents involving the deaths of Palestinians, including the 2024 killing of 5-year-old Hind Rajab in Gaza. A cancer vaccine for melanoma sparks hope of treatment for a variety of tumors. And humanoid robots show off their every day skills at the World Robot Conference.

Neuroscientist and educator Jared Cooney Horvath testified before the Senate earlier this year on the impacts of classroom technology. Horvath shares his thoughts on screen time and education.Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert have more information.Neuroscientist and educator Jared Cooney Horvath testified before the Senate earlier this year on the impacts of classroom technology. Horvath shares his thoughts on screen time and education.For America's 250th birthday, USAA unveiled The National Military Monument in Washington, D.C., a living tribute to the more than 41 million veterans who have served the U.S. USAA Senior Vice President Rob Braggs shares that the monument will stay open through Nov. 12. Visit https://monument250.usaa360.com/ for more information. (Sponsored by USAA)Students nationwide are grappling with a new reality -- AI-generated pornography, sometimes featuring themselves or someone they know. CBS News found more than a dozen AI "nudify" apps easily accessible in app stores, some without age restrictions. Jo Ling Kent has more.The NFL is launching a new "celly" campaign to honor the tradition of touchdown celebration dances in the end zone. Jason Allen joins the Houston Texans at their training facility to learn more.

Digital Content Editor, Barbara Friedman, shared her top three stories trending online. Views and News with Clarence Ford is the mid-morning show on CapeTalk. This 3-hour-long programme shares and reflects a broad array of perspectives. It is inspirational, passionate and positive. Host Clarence Ford’s gentle curiosity and dapper demeanour leave listeners feeling motivated and empowered. Known for his love of jazz and golf, Clarrie covers a range of themes including relationships, heritage and philosophy. Popular segments include Barbs’ Wire at 9:30 am (Mon-Thurs) and The Naked Scientist at 9:30 on Fridays. Thank you for listening to a podcast from Views & News with Clarence Ford Listen live on Primedia+ weekdays between 09:00 and 12:00 (SA Time) to Views and News with Clarence Ford broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/erjiQj2 or find all the catch-up podcasts here https://buff.ly/BdpaXRn Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

President Donald Trump weighs in on the potential for US-Iran peace talks as regional tensions widen. We have the latest congressional lawmaker facing an ethics investigation. We'll tell you about a big change in the Texas track meet stabbing case ahead of the defendant's hearing for a new trial. A win for cancer research is being felt on Wall Street. Plus, the president shows off his latest White House makeover projects. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Plus: Target's second-quarter sales suggest the retailer's turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi's prediction markets. Alex Ossola hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Elizabeth Burton, Chief Strategist at Fortress Investment Group, assesses the broader investment landscape and where she sees opportunity as investors balance growth against emerging risks. Health care takes center stage as Courtney Breen of Bernstein breaks down developments involving Moderna and Merck and what they mean for biotech and pharmaceutical investors as both stocks soar following promising results in a late-stage trial. Moderna jumped nearly 200%. Lo Toney of Plexo Capital tackles a key question in the AI race: is OpenAI losing momentum? Our Eunice Yoon reports on a Chinese humanoid robotics company going public and what the deal reveals about China's ambitions in robotics and AI. Finally, Kate McShane of Goldman Sachs analyzes the latest retail movers, reacts to Target and previews Walmart earnings as investors search for fresh signals on the health of the consumer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

────────────────────────────────────────[00:02:23]Moderna Launching an mRNA Cancer Vaccine — for Patients Who Already Have Metastatic CancerThe shot caused the cancer explosion; now programming immune-compromised patients to produce tumor proteins; control group gets a different mRNA — no placebo.────────────────────────────────────────[00:10:05]Scientists Warn Moderna's mRNA Cancer Vaccine May Itself Cause Tumor GrowthJessica Rose: undisclosed antigens prevent independent safety assessment; Dr. Hoecker: counterintuitive to promote a therapy that causes cancer; FDA will approve it anyway.────────────────────────────────────────[00:34:38]Whistleblower Doctor: Booster Interval Timed to Hit White Blood Cell Production While DownFirst dose cuts production by 50%; second drops it to 25%; booster carries 81 strands of foreign bacteria the weakened immune system cannot fight.────────────────────────────────────────[00:38:48]Acosta Gave Epstein a Sweetheart Deal Because He Was Told Epstein Was Intelligence — Ken Starr Then Became His Defense AttorneyThe same Starr who gave Clinton a pass became Epstein's lawyer; a victim who refused to speak was forced forward when DOJ published her name.────────────────────────────────────────[00:40:32]Trump Sent Ivanka as a Teenager to Brunel — Modeling Agent Later Convicted of Rape and PedophiliaBrunel trafficked women into debt bondage for Epstein; the Uzbek woman now speaking out was one of his victims; Brunel died in prison in 2022.────────────────────────────────────────[01:14:55]China Cut Oil Consumption to Prevent a Global Depression — Trump Appears to Be Trying to Create OneChinese foreign minister: the Strait was open before the war; US-Israel operations created the crisis; China offset 5% of the 20% lost by cutting its consumption.────────────────────────────────────────[01:21:11]After the Iran War, Both Sides Have Revealed Their Limits — Next Conflict Requires a Domestic TriggerUS and Israel cannot change Tehran by force; Iran cannot inflict critical damage; both will prepare for a conflict requiring something to happen on American soil.────────────────────────────────────────[01:25:07]Hegseth Asks Congress for $1.5 Trillion for a War Trump Already Declared WonSenator to Hegseth: unlimited bomb money while cutting food, healthcare, and farm support; Palmer Luckey is building autonomous Terminator drones with Thiel's money.────────────────────────────────────────[01:52:30]The Covenant With Moses Was Conditional — Israel Broke It and God Destroyed the Nation ForeverPalestine today is a devilish counterfeit; the Old Testament testifies of Christ, not an ethnic group or political state — fundamental error of Christian Zionism.────────────────────────────────────────[01:55:08]Trump Contradicts Himself in the Same Sentence — Desperate to Meet Iran, But Not ReadyIran's missiles change speed mid-flight defeating every US defense system; Trump blamed Jordan attack on Jordanians. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

────────────────────────────────────────[00:02:23]Moderna Launching an mRNA Cancer Vaccine — for Patients Who Already Have Metastatic CancerThe shot caused the cancer explosion; now programming immune-compromised patients to produce tumor proteins; control group gets a different mRNA — no placebo.────────────────────────────────────────[00:10:05]Scientists Warn Moderna's mRNA Cancer Vaccine May Itself Cause Tumor GrowthJessica Rose: undisclosed antigens prevent independent safety assessment; Dr. Hoecker: counterintuitive to promote a therapy that causes cancer; FDA will approve it anyway.────────────────────────────────────────[00:34:38]Whistleblower Doctor: Booster Interval Timed to Hit White Blood Cell Production While DownFirst dose cuts production by 50%; second drops it to 25%; booster carries 81 strands of foreign bacteria the weakened immune system cannot fight.────────────────────────────────────────[00:38:48]Acosta Gave Epstein a Sweetheart Deal Because He Was Told Epstein Was Intelligence — Ken Starr Then Became His Defense AttorneyThe same Starr who gave Clinton a pass became Epstein's lawyer; a victim who refused to speak was forced forward when DOJ published her name.────────────────────────────────────────[00:40:32]Trump Sent Ivanka as a Teenager to Brunel — Modeling Agent Later Convicted of Rape and PedophiliaBrunel trafficked women into debt bondage for Epstein; the Uzbek woman now speaking out was one of his victims; Brunel died in prison in 2022.────────────────────────────────────────[01:14:55]China Cut Oil Consumption to Prevent a Global Depression — Trump Appears to Be Trying to Create OneChinese foreign minister: the Strait was open before the war; US-Israel operations created the crisis; China offset 5% of the 20% lost by cutting its consumption.────────────────────────────────────────[01:21:11]After the Iran War, Both Sides Have Revealed Their Limits — Next Conflict Requires a Domestic TriggerUS and Israel cannot change Tehran by force; Iran cannot inflict critical damage; both will prepare for a conflict requiring something to happen on American soil.────────────────────────────────────────[01:25:07]Hegseth Asks Congress for $1.5 Trillion for a War Trump Already Declared WonSenator to Hegseth: unlimited bomb money while cutting food, healthcare, and farm support; Palmer Luckey is building autonomous Terminator drones with Thiel's money.────────────────────────────────────────[01:52:30]The Covenant With Moses Was Conditional — Israel Broke It and God Destroyed the Nation ForeverPalestine today is a devilish counterfeit; the Old Testament testifies of Christ, not an ethnic group or political state — fundamental error of Christian Zionism.────────────────────────────────────────[01:55:08]Trump Contradicts Himself in the Same Sentence — Desperate to Meet Iran, But Not ReadyIran's missiles change speed mid-flight defeating every US defense system; Trump blamed Jordan attack on Jordanians. ──────────────────────────────────────── Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code “KNIGHT” For high quality made in America products go to HomeSteadProducts.shop and use promo code “Knight” for 10% off your purchases Find out more about the show and where you can watch it at TheDavidKnightShow.com If you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-show Or you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

What if the cancer diagnosis your doctor gave you is technically correct — but the treatment they chose has almost nothing to do with your actual cancer?This week, I sat down with Ed Clay, co-founder of TAM Center and Stem Cells, one of the world's most advanced translational medicine hospitals in Tijuana, Mexico. Ed started this journey the way most great things do — out of love. His mom got sick with no options in the US, so he bought a hospital and hired back the staff. She came in in a wheelchair and walked out.But what Ed has built since then? That's what blew my mind. His team — including the former chief of infectious disease at the NIH and the scientist who invented a test that reads 10,000 proteins at once — can sequence 20,000 of your cancer genes. Most US oncologists test 90.He dropped a bomb: there is not a single product on the market right now that can accurately detect cancer early through a blood test. Companies claiming otherwise? He's read their data. It's four patients.He also revealed why two people with the exact same cancer diagnosis can need completely different treatments — and why that distinction could be the difference between responding and not.This conversation will change how you think about what cancer actually is, and what it means to actually fight it.What we talk about:Why "ovarian cancer" in two different women can be two completely different diseases at the genetic levelThe lie behind liquid biopsy tests claiming to detect cancer in your bloodHow TAM goes from discovery to treating a patient in 6–12 months instead of 7 yearsA UFC champion's sister went from "weeks to live" to cancer-free in two months — here's what they foundZombie cells, senescence, and the peptide vaccine that could be the actual fountain of youthWhy combining genomics, proteomics, and methylation data could unlock cures for almost everythingCoffee enemas, Gerson therapy, and what happens to your body on day threeEpisode Links & Resources:Website: The Tam Center - https://thetamcenter.com | CPI Stem Cells - https://cellularperformanceinstitute.com/Podcast: https://www.edclayshow.com/Instagram: https://www.instagram.com/edclayofficialConnect with Tracy:Website: ⁠https://tracyduhs.com/⁠Hydration Shop: ⁠https://sanctuarysd.com/⁠Instagram: ⁠@tracyduhs⁠Flow FAM Community: ⁠https://tracyduhs.com/join-flow-fam/⁠

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss a case out of Australia—where an owner helped drive development of an mRNA vaccine for their dog's mast cell disease—that has sparked big questions in the exam room. In this episode, they unpack the implications for clinical practice, client expectations, and how veterinarians can navigate conversations around emerging, highly personalized therapies. Brought to you by Zoetis Resources: https://news.unsw.edu.au/en/meet-the-man-who-designed-a-cancer-vaccine-for-his-dog https://www.zoetisus.com/petcare/care-is-your-calling/ Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Beth Molleson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

Headlines:  – Welcome To Mo News (02:00) – Iran Ceasefire Countdown As Latest Pakistan Talks Look Iffy (07:10) – Energy Secretary Says Gas Prices May Stay Above $3 A Gallon Until 2027 (14:00) – A Look At The Democrat-Israel Divorce (15:00) – Apple Names John Ternus CEO, Replacing Tim Cook, Who Becomes Chairman (26:50) – Trump Labor Secretary Resigns Amid Scandal (30:00) – FBI Director Sues The Atlantic For $250 Million Over Story On Alleged Excessive Drinking (33:00) – As Measles Takes Toll on Kids, Anti-Vaxxers Have Change of Heart (38:10) – Pancreatic Cancer mRNA Vaccine Shows Lasting Results In Early Trial (41:00) – Back To Back Boston Marathon Winners (43:00) – Humanoid Robot Wins Half-Marathon and Smashes Humans' Record (44:10) – On This Day In History (47:10) Thanks To Our Sponsors:  – ⁠Boll & Branch⁠ – 15% off first order, plus free shipping | Code: MONEWS –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – Incogni - 60% off an annual plan| Code: MONEWS – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off – ShipStation - Try for free for 60 days | Code: MONEWS – Shopify – $1 per-month trial | Code: MONEWS – LMNT | Free Sample Pack with any LMNT drink mix or 12oz cans purchase – Aura Frames | $25 dollars off the Carver Mat frame | Code: MONEWS

The US military fires on and seizes an Iranian ship. Eight children were killed in the worst mass shooting in the country, since 2024.  President Trump announces an Oval Office Bible reading, amid a feud with the Pope. Promising new data from a pancreatic cancer vaccine trial. Plus, a hot air balloon makes an emergency landing in a backyard. Learn more about your ad choices. Visit podcastchoices.com/adchoices

How much do you love your dog? Well, our next story is about a Sydney man who's definitely in the running to be dog-dad of the year. Back in 2024, Paul Conyngham found out his dog Rosie had cancer. When traditional treatment routes weren't working ... being a tech guy, he turned to Artificial Intelligence and some very smart people for help. Chat GPT advised him to look into immunotherapy and was told that the University of New South Wales Ramaciotti Center for Genomics might be able to help. And help they did Paul was able to get Rosie's genomic sequencing. From there he was able to dig into the DNA data and identify a potential treatment. After a setback with a drugmaker, a team at the university developed a world-first personalised cancer treatment for Rosie. While not completely cured, her health is now doing much better and crucially for Paul, she has more time. To tell Emile more about the exciting science behind this medicine is Professor Martin Smith, Director of the Ramaciotti Centre for Genomics.

A tech entrepreneur with no biology background used ChatGPT, AlphaFold, and Grok to design a cancer vaccine for his dog (tumor shrank 75%), Pokemon Go players unknowingly generated 30 billion images now used to train delivery robots, and 4D Gaussian splats are streaming in real time in your browser.00:00 Introduction01:50 AI-Designed Cancer Vaccine for a Dog23:29 Pokemon Go Secretly Trained AI Robots44:03 4D Gaussian Splats Streaming in BrowserPowered by Dell Pro Precision : https://creatorfolio.co/badxstudiohttps://creatorfolio.co/badxstudio3

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with a medical success story with a new cancer vaccine, the importance of a strong immune system, and how we are inadvertently aging ourselves faster. Next, Doug and Dr. Ken address an increase in life expectancy, a study showing night owls have a higher risk of heart disease than early birds, and the state of public health (specifically where we're at with measles outbreaks. Moving on, Dr. Ken breaks down how weight-loss drugs are being shown to have a positive effect on heart-health when helping with weight loss. Continuing on with the discussion on heart-health and optimal cardiovascular awareness, Doug and Dr. Ken discuss what the numbers of blood pressure mean and why spikes happen at various times. Then, Doug and Dr. Ken address listener questions with a strong focus on the MIT Smart Pill, a biodegradable antenna that transmits a wireless signal from the stomach to confirm medication has been swallowed. Designed to improve adherence for high-risk patients, the pill uses zinc and cellulose materials to safely dissolve within a week, leaving only a tiny, non-biodegradable RFID chip that is naturally excreted. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Intel's (INTC) recent rally isn't the only one investors should pay attention to, says Diane King Hall. She points to Moderna (MRNA) hitting a 52-week high after a trial drug to treat melanoma posted positive results. On the earnings front, Diane explains why investors are shaking off Procter & Gamble's (PG) mixed earnings and Abbott's (ABT) post-earnings sell-off. ======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some fascinating breakthroughs and regulatory updates that are shaping the future of healthcare.Starting with a pivotal advancement in Alzheimer's research, a new drug has shown promising results in slowing cognitive decline in patients with early-stage Alzheimer's disease. This innovative therapy targets amyloid plaques in the brain, which are believed to play a central role in the progression of Alzheimer's. Recent clinical trials have demonstrated that patients receiving this treatment experienced a significant reduction in the rate of cognitive deterioration compared to those on a placebo. The implications of this development are profound, offering hope for millions affected by this debilitating condition. As researchers continue to unravel the mysteries of Alzheimer's, this breakthrough marks a crucial step forward in understanding and potentially halting disease progression.Moving on to regulatory news, the FDA has recently granted accelerated approval to a novel gene therapy for a rare genetic disorder known as spinal muscular atrophy (SMA). This condition, which affects motor neurons and leads to muscle wasting and weakness, primarily impacts infants and young children. The newly approved therapy works by delivering a functional copy of the defective gene directly into the patient's cells. Early trials have shown remarkable improvements in motor function and survival rates among treated infants. This approval represents not only a lifeline for affected families but also underscores the growing potential of gene therapies to address previously untreatable genetic diseases.In another significant development, researchers have unveiled a groundbreaking study on an experimental cancer vaccine that has demonstrated efficacy in preventing tumor growth in preclinical models. Unlike traditional vaccines aimed at infectious diseases, this cancer vaccine is designed to harness the body's immune system to specifically target and destroy cancer cells. The study's results indicate that the vaccine was successful in generating a robust immune response, which significantly inhibited tumor progression. If these findings can be replicated in human trials, it could open new avenues for cancer prevention and treatment, particularly for cancers with limited therapeutic options.Shifting our focus to trends within the industry, there's an increasing emphasis on personalized medicine, reflecting a broader shift towards treatments tailored to individual patients' genetic profiles. This approach aims to optimize therapeutic efficacy while minimizing adverse effects by considering each patient's unique genetic makeup. Advances in genomic sequencing technologies and bioinformatics are driving this transformation, enabling more precise diagnostics and targeted therapies. As personalized medicine continues to evolve, it holds the promise of revolutionizing how diseases are treated and managed in clinical practice.On the topic of drug approvals, a new oral medication for type 2 diabetes has received regulatory clearance after demonstrating superior glycemic control compared to existing treatments. This drug belongs to a novel class of medications that enhance insulin sensitivity and reduce glucose production by targeting specific metabolic pathways. Clinical trials indicated significant improvements in blood sugar levels and overall metabolic health among participants. Given the global prevalence of type 2 diabetes and its associated health complications, such advancements are crucial for improving patient outcomes and reducing healthcare burdens.Lastly, focusing on collaborations within the industry, several prominent pharmaceutical companies have announced partnerships aimed at accelerating research in infectious diseases.Support the show

TWiV discusses the impact of vaccinating with Gardasil-9 adult women who are human papillomavirus positive or with confirmed squamous intraepithelial lesions, and human monoclonal antibodies that target the monkeypox virus A35 protein which protect against lethal disease. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV Immune 100 live at the Incubator Long tailed macaques are now officially endangered (Science) Iceland now has mosquitoes (npr) Impact of Gardasil-9 on adult women who are HPV+ or SIL+ (Viruses) Human mAbs that protect against mpox disease (Cell) Timestamps by Jolene Ramsey. Thanks! Weekly Picks Brianne – Civet coffee: The real chemistry behind this bizarre luxury drink Kathy – Astronomy photographer of the year awards Rich – Katherine Swan Ginsburg Humanism in Medicine Program Alan – Parasitic worms can use static electricity to latch onto flies midair Vincent – How to get the best night's sleep: what the science says Listener Pick Bradon – Elevated Access Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

With more and more new research coming out on cancer treatments, it seems that we're bound to have some sort of breakthrough soon. Today Dr. Jonathan Karp and student producer Kaya Basatemur discuss an article that might just be one of the newest and best concepts that we have right now for advancement of cancer treatment. This article was published on October 9th, 2025, in the Cell Reports Medicine journal; since its publication it has become very well-discussed and brought up in the press. So what is this "cancer vaccine"? Does it work for all types of cancer? Is this a viable concept to continue researching in hopes of a cure for cancer? Tune in to this week's episode of Health 411 to find out!

Topics discussed on today's show: National Teddy Bear Day, Best Way To Get Rid Of A Body, Birthdays, History Quiz, Geographic Tongue, Cini Minis, Worst Scare of your Life, Ice, Drunk Raccoon, Spit Takes, Sports News, Super Tramp, Cancer Vaccine, Clock Botching, Worse Mistakes At Work, and Apologies.

French Prime Minister Bayrou is ousted in a no-confidence vote, Japan's Prime Minister Shigeru Ishiba resigns, The opposition wins Buenos Aires' legislative election, Six are killed in a shooting at Jerusalem bus stop, 890 people are arrested in the U.K. at a pro-Palestine protest,  Boko Haram kills over 60 in a Nigeria village attack, The U.S. Supreme Court allows the LA immigration raids to resume, The U.S. will send 300 Hyundai workers back to South Korea, A judge blocks the Trump Admin's ending of Venezuelan and Haitian temporary protected status, Erin Patterson is sentenced to life in the Australian mushroom murder trial, and Russia's cancer vaccine shows 100% efficacy in clinical trials. Sources: www.verity.news

PATREON: https://www.patreon.com/blackstreetboysDISCORD: https://discord.gg/UTnCxNBDTVTWITCH: https://www.twitch.tv/bsbliveUse code "BSBPOD" for 10% any KickBuilds Lego shoe set SITEWIDE!: https://kickbuilds.com/TWITCH:BSB: https://www.twitch.tv/bsbliveBrandon: https://www.Twitch.tv/RangeBrothaRob: https://www.twitch.tv/budabearrPATREON: https://www.patreon.com/blackstreetboysDISCORD: https://discord.gg/UTnCxNBDTVApple Podcasts: https://podcasts.apple.com/us/podcast/blackstreet-boys-podcast-

"Ripped From The Headlines" is a new series for Breaking the Code, where Sonika and Gabe react to a news story with a medical anthropology lens. On this edition, they react to Anixa Biosciences' breast cancer vaccine completing phase one of clinical testing. The notion of a cancer vaccine sparked a variety of conversation topics from women's health to vaccine culture. If you love to listen to rich, fast-evolving conversations, then give this a listen and let us know what you think!Follow us on LinkedIn

Thanks to our Partners, NAPA TRACS, and Today's Class This episode features Brakes for Breasts co-founders Leigh Anne Best and Laura Frank, along with Cleveland Clinic researcher Dr. Justin Johnson, as they celebrate the automotive industry's role in raising over $2 million for breast cancer vaccine research. They share the initiative's grassroots beginnings, its 100% donation to research model, and provide an update on the vaccine's progress, highlighting the completion of Phase One trials and the upcoming launch of Phase Two. A key highlight of the campaign: During October, independent auto repair shops across the U.S. offer free brake pads to customers. For every brake service performed, the customer receives their brake pads at no cost and only pays for labor and other parts. In turn, each participating shop donates 10% of the brake service total to the Cleveland Clinic Breast Cancer Vaccine Research Fund. The episode also shares the inspiring story of Jennifer Davis, the first vaccine recipient, and encourages more shops to get involved in this unique, community driven fundraising effort that's helping fuel groundbreaking research. Show Notes: Watch Full Video Episode The First Breast Cancer Vaccine Trial Recipient: Jennifer Davis [CC 111]: https://remarkableresults.biz/remarkable-results-radio-podcast/cc111/ Introduction (00:00:00) Celebrating the $2 Million Milestone (00:03:08) Origin Story of Breaks for Breasts (00:03:46) Connection to Cleveland Clinic and Dr. Tuohy (00:06:01) Personal Motivations for Founding (00:06:55) Industry Call to Action and Broader Impact (00:07:31) Expanding Research Beyond Breast Cancer (00:10:09) Clinical Trials Overview: Phase One (00:12:14) Clinical Trials: Phase Two and Three Plans (00:14:08) How Research Funding Works at Cleveland Clinic (00:19:42) 2024 Check Presentation and Fundraising Impact (00:21:03) Jennifer Davis: The First Clinical Trial Patient (00:23:38) Hope and Realistic Expectations...

Why does cold water take your breath away? And why is it cold when you leave the cold water? What smells does an ant produce? Is there a psychological aspect to cramp? Are there any new asthma treatments in the pipeline? Are people getting vaccinated against cancer? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Why does cold water take your breath away? And why is it cold when you leave the cold water? What smells does an ant produce? Is there a psychological aspect to cramp? Are there any new asthma treatments in the pipeline? Are people getting vaccinated against cancer? Dr Chris Smith and Clarence Ford have all the answers... Like this podcast? Please help us by supporting the Naked Scientists

Story at-a-glance Gardasil's ability to prevent cervical cancer is being questioned, with experts citing a lack of long-term studies proving reduced cancer rates While Gardasil targets specific HPV strains, concerns exist that it allows for the emergence of other harmful strains, thus canceling the vaccine's intended benefits Reports of severe side effects, including heart complications and even deaths, raise serious safety concerns, warranting caution The vaccine's aggressive marketing, despite the proven effectiveness of regular pap smears, suggests Gardasil's benefits have been exaggerated while risks have been downplayed Lawsuits alleging that Merck concealed risks and overstated Gardasil's efficacy are underway, casting doubt on the company's transparency and raising trust issues regarding pharmaceutical marketing

Physician & mRNA pioneer, Robert Malone, MD, joins Del to discuss tech giant Larry Ellison's recent promotion of employing mRNA vaccine technology to fight cancer. Get his expert view on his serious concerns about this technology that has already been proven to be dangerous and how Moderna has nearly gone bankrupt in the past after years of failed attempts of creating a vaccine for cancer. Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Patrick Bet-David, Tom Ellsworth, Vincent Oshana, and Adam Sosnick cover Trump's clash with John Bolton, Larry Ellison's groundbreaking cancer vaccine, the Obama's rumored divorce, and Trump's war against woke culture. ----